Gyrus PlasmaKinetic bipolar coagulation device for liver resection

Area of Science:

• Hepatobiliary surgery
• Surgical technology
• Minimally invasive procedures

Background:

• Liver parenchymal transection poses risks of significant blood loss and morbidity.
• The Gyrus PlasmaKinetic coagulation device is a novel technology for liver resection.
• Initial experience with this device in both cirrhotic and non-cirrhotic patients is presented.

Purpose of the Study:

• To evaluate the initial experience with the Gyrus PlasmaKinetic coagulation device for liver parenchymal resection.
• To assess the safety and efficacy of the device in cirrhotic and non-cirrhotic patients.
• To compare outcomes between cirrhotic and non-cirrhotic patient groups.

Main Methods:

• 51 consecutive liver resections were performed using the Gyrus PlasmaKinetic coagulator between July 2005 and August 2007.
• Outcomes evaluated included blood transfusion requirements, operating time, hospital stay duration, and major complications.
• Patients were stratified into cirrhotic (n=11) and non-cirrhotic (n=40) groups for comparative analysis.

Main Results:

• The study included 51 patients (34 male, 17 female; median age 56 years).
• Overall, 41% of patients required blood transfusions; two biliary leaks occurred in non-cirrhotic patients before device optimization.
• Median operating time was 260 minutes, and median hospital stay was 9 days.

Conclusions:

• The Gyrus PlasmaKinetic coagulation device is a safe and effective instrument for hepatic parenchymal transection during liver resection.
• The device demonstrates utility in both cirrhotic and non-cirrhotic patient populations.
• Optimization of device settings may further reduce complications like biliary leaks.